Product Information
TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3383 per EA under NDC 62332021130. Its NADAC has been published 521 times since Oct 12, 2016.
FDA first approved this application on Feb 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 80 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332021130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203010FDA Approved
2/25/2014
TE Code
AB
On Market Since
6/25/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has been published 521 times since Oct 12, 2016, and over the history we have for it it has declined 89.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3383 per EA |
|---|---|
| All-time high | $3.2326 (Dec 14, 2016) |
| All-time low | $0.3383 (Sep 23, 2026) |
| 52-week high | $0.4064 |
| 52-week low | $0.3383 |
| Median price | $1.2059 |
| Average price | $1.2818 |
| Largest weekly change | +79.0% (May 19, 2021) |
| Weeks tracked | 521 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Telmisartan and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $0.3383 per EA (NDC 62332021130), effective Sep 30, 2026.
How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has declined 89.3%. It has been tracked across 521 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?
Since Oct 12, 2016, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB has ranged from a low of $0.3383 (Sep 23, 2026) to a high of $3.2326 (Dec 14, 2016), with a median of $1.2059 per EA.
Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB?
TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB (NDC 62332021130) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.